Cannabis and Tobacco Co-Use Is Associated With Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · 2026-08 · 11 (8) · 996-1006
DOI: 10.1016/j.bpsc.2026.03.021 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2026-08. Verfasst von Daniel Bello und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Psychotic Disorders, Cognitive Dysfunction, Marijuana Use, Tobacco Use. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.
- Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
- Semel Institute for Neuroscience and Human Behavior, Departments of Psychiatry and Behavioral Sciences and Psychology, University of California Los Angeles, Los Angeles, California.
- Department of Psychiatry, University of California San Diego, La Jolla, California.
- Department of Psychology and Psychiatry, Yale University, New Haven, Connecticut.
- Northwell Health, New Hyde Park, New York; Institute for Behavioral Science, Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, New York; Department of Psychiatry, Donald and Barbara Zucker S…
Förderung
- National Institutes of Health
Zitieren
APA
Bello, D., Connolly, J. G., Addington, J., Bearden, C. E., Cadenhead, K., Cannon, T. D., Cornblatt, B., Keshavan, M., Mathalon, D. H., Perkins, D. O., Seidman, L., Stone, W. S., Tsuang, M. T., Walker, E. F., Woods, S., Brady, R. O., Carrión, R. E., & Ward, H. B. (2026). Cannabis and Tobacco Co-Use Is Associated With Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 11(8), 996-1006. https://doi.org/10.1016/j.bpsc.2026.03.021
Vancouver
Bello D, Connolly JG, Addington J, Bearden CE, Cadenhead K, Cannon TD, et al. Cannabis and Tobacco Co-Use Is Associated With Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 2026;11(8):996-1006. doi:10.1016/j.bpsc.2026.03.021
BibTeX
@article{Bello2026,
author = {Bello, Daniel and Connolly, Jillian G and Addington, Jean and Bearden, Carrie E and Cadenhead, Kristin and Cannon, Tyrone D and Cornblatt, Barbara and Keshavan, Matcheri and Mathalon, Daniel H and Perkins, Diana O and Seidman, Larry and Stone, William S and Tsuang, Ming T and Walker, Elaine F and Woods, Scott and Brady, Roscoe O and Carrión, Ricardo E and Ward, Heather Burrell},
title = {Cannabis and Tobacco Co-Use Is Associated With Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis},
journal = {Biological Psychiatry: Cognitive Neuroscience and Neuroimaging},
year = {2026},
volume = {11},
number = {8},
pages = {996--1006},
doi = {10.1016/j.bpsc.2026.03.021}
}
EUVIMED